Cargando…

Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries

Chikungunya virus (CHIKV) is a re-emerging mosquito-borne human pathogen that causes chikungunya fever, which is typically accompanied by severe joint pain. In Asia, serological evidence indicated that CHIKV first emerged in 1954. From the 1950’s to 2005, sporadic CHIKV infections were attributed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Khongwichit, Sarawut, Chansaenroj, Jira, Chirathaworn, Chintana, Poovorawan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638460/
https://www.ncbi.nlm.nih.gov/pubmed/34857000
http://dx.doi.org/10.1186/s12929-021-00778-8
_version_ 1784608949989801984
author Khongwichit, Sarawut
Chansaenroj, Jira
Chirathaworn, Chintana
Poovorawan, Yong
author_facet Khongwichit, Sarawut
Chansaenroj, Jira
Chirathaworn, Chintana
Poovorawan, Yong
author_sort Khongwichit, Sarawut
collection PubMed
description Chikungunya virus (CHIKV) is a re-emerging mosquito-borne human pathogen that causes chikungunya fever, which is typically accompanied by severe joint pain. In Asia, serological evidence indicated that CHIKV first emerged in 1954. From the 1950’s to 2005, sporadic CHIKV infections were attributed to the Asian genotype. However, the massive outbreak of CHIKV in India and the Southwest Indian Ocean Islands in 2005 has since raised chikungunya as a worldwide public health concern. The virus is spreading globally, but mostly in tropical and subtropical regions, particularly in South and Southeast Asia. The emergence of the CHIKV East/Central/South African genotype-Indian Ocean lineage (ECSA-IOL) has caused large outbreaks in South and Southeast Asia affected more than a million people over a decade. Notably, the massive CHIKV outbreaks before 2016 and the more recent outbreak in Asia were driven by distinct ECSA lineages. The first significant CHIKV ECSA strains harbored the Aedes albopictus-adaptive mutation E1: A226V. More recently, another mass CHIKV ECSA outbreak in Asia started in India and spread beyond South and Southeast Asia to Kenya and Italy. This virus lacked the E1: A226V mutation but instead harbored two novel mutations (E1: K211E and E2: V264A) in an E1: 226A background, which enhanced its fitness in Aedes aegypti. The emergence of a novel ECSA strain may lead to a more widespread geographical distribution of CHIKV in the future. This review summarizes the current CHIKV situation in Asian countries and provides a general overview of the molecular virology, disease manifestation, diagnosis, prevalence, genotype distribution, evolutionary relationships, and epidemiology of CHIKV infection in Asian countries over the past 65 years. This knowledge is essential in guiding the epidemiological study, control, prevention of future CHIKV outbreaks, and the development of new vaccines and antivirals targeting CHIKV.
format Online
Article
Text
id pubmed-8638460
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86384602021-12-03 Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries Khongwichit, Sarawut Chansaenroj, Jira Chirathaworn, Chintana Poovorawan, Yong J Biomed Sci Review Chikungunya virus (CHIKV) is a re-emerging mosquito-borne human pathogen that causes chikungunya fever, which is typically accompanied by severe joint pain. In Asia, serological evidence indicated that CHIKV first emerged in 1954. From the 1950’s to 2005, sporadic CHIKV infections were attributed to the Asian genotype. However, the massive outbreak of CHIKV in India and the Southwest Indian Ocean Islands in 2005 has since raised chikungunya as a worldwide public health concern. The virus is spreading globally, but mostly in tropical and subtropical regions, particularly in South and Southeast Asia. The emergence of the CHIKV East/Central/South African genotype-Indian Ocean lineage (ECSA-IOL) has caused large outbreaks in South and Southeast Asia affected more than a million people over a decade. Notably, the massive CHIKV outbreaks before 2016 and the more recent outbreak in Asia were driven by distinct ECSA lineages. The first significant CHIKV ECSA strains harbored the Aedes albopictus-adaptive mutation E1: A226V. More recently, another mass CHIKV ECSA outbreak in Asia started in India and spread beyond South and Southeast Asia to Kenya and Italy. This virus lacked the E1: A226V mutation but instead harbored two novel mutations (E1: K211E and E2: V264A) in an E1: 226A background, which enhanced its fitness in Aedes aegypti. The emergence of a novel ECSA strain may lead to a more widespread geographical distribution of CHIKV in the future. This review summarizes the current CHIKV situation in Asian countries and provides a general overview of the molecular virology, disease manifestation, diagnosis, prevalence, genotype distribution, evolutionary relationships, and epidemiology of CHIKV infection in Asian countries over the past 65 years. This knowledge is essential in guiding the epidemiological study, control, prevention of future CHIKV outbreaks, and the development of new vaccines and antivirals targeting CHIKV. BioMed Central 2021-12-02 /pmc/articles/PMC8638460/ /pubmed/34857000 http://dx.doi.org/10.1186/s12929-021-00778-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Khongwichit, Sarawut
Chansaenroj, Jira
Chirathaworn, Chintana
Poovorawan, Yong
Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries
title Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries
title_full Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries
title_fullStr Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries
title_full_unstemmed Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries
title_short Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries
title_sort chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in asian countries
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638460/
https://www.ncbi.nlm.nih.gov/pubmed/34857000
http://dx.doi.org/10.1186/s12929-021-00778-8
work_keys_str_mv AT khongwichitsarawut chikungunyavirusinfectionmolecularbiologyclinicalcharacteristicsandepidemiologyinasiancountries
AT chansaenrojjira chikungunyavirusinfectionmolecularbiologyclinicalcharacteristicsandepidemiologyinasiancountries
AT chirathawornchintana chikungunyavirusinfectionmolecularbiologyclinicalcharacteristicsandepidemiologyinasiancountries
AT poovorawanyong chikungunyavirusinfectionmolecularbiologyclinicalcharacteristicsandepidemiologyinasiancountries